Cargando…

Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs

During the last twenty years, organic fluorination chemistry established itself as an important tool to get a biologically active compound. This belief can be supported by the fact that every year, we are getting fluorinated drugs in the market in extremely significant numbers. Last year, also ten f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandra, Girish, Singh, Durg Vijay, Mahato, Gopal Kumar, Patel, Samridhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099028/
https://www.ncbi.nlm.nih.gov/pubmed/37362786
http://dx.doi.org/10.1007/s11696-023-02804-5
_version_ 1785024959145312256
author Chandra, Girish
Singh, Durg Vijay
Mahato, Gopal Kumar
Patel, Samridhi
author_facet Chandra, Girish
Singh, Durg Vijay
Mahato, Gopal Kumar
Patel, Samridhi
author_sort Chandra, Girish
collection PubMed
description During the last twenty years, organic fluorination chemistry established itself as an important tool to get a biologically active compound. This belief can be supported by the fact that every year, we are getting fluorinated drugs in the market in extremely significant numbers. Last year, also ten fluorinated drugs have been approved by FDA and during the COVID-19 pandemic, fluorinated drugs played a very crucial role to control the disease and saved many lives. In this review, we surveyed all ten fluorinated drugs approved by FDA in 2021 and all fluorinated drugs which were directly-indirectly used during the COVID-19 period, and emphasis has been given particularly to their synthesis, medicinal chemistry, and development process. Out of ten approved drugs, one drug pylarify, a radioactive diagnostic agent for cancer was approved for use in positron emission tomography imaging. Also, very briefly outlined the significance of fluorinated drugs through their physical, and chemical properties and their effect on drug development. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-10099028
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Versita
record_format MEDLINE/PubMed
spelling pubmed-100990282023-04-14 Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs Chandra, Girish Singh, Durg Vijay Mahato, Gopal Kumar Patel, Samridhi Chem Zvesti Review During the last twenty years, organic fluorination chemistry established itself as an important tool to get a biologically active compound. This belief can be supported by the fact that every year, we are getting fluorinated drugs in the market in extremely significant numbers. Last year, also ten fluorinated drugs have been approved by FDA and during the COVID-19 pandemic, fluorinated drugs played a very crucial role to control the disease and saved many lives. In this review, we surveyed all ten fluorinated drugs approved by FDA in 2021 and all fluorinated drugs which were directly-indirectly used during the COVID-19 period, and emphasis has been given particularly to their synthesis, medicinal chemistry, and development process. Out of ten approved drugs, one drug pylarify, a radioactive diagnostic agent for cancer was approved for use in positron emission tomography imaging. Also, very briefly outlined the significance of fluorinated drugs through their physical, and chemical properties and their effect on drug development. GRAPHICAL ABSTRACT: [Image: see text] Versita 2023-04-13 /pmc/articles/PMC10099028/ /pubmed/37362786 http://dx.doi.org/10.1007/s11696-023-02804-5 Text en © Institute of Chemistry, Slovak Academy of Sciences 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Chandra, Girish
Singh, Durg Vijay
Mahato, Gopal Kumar
Patel, Samridhi
Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs
title Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs
title_full Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs
title_fullStr Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs
title_full_unstemmed Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs
title_short Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs
title_sort fluorine-a small magic bullet atom in the drug development: perspective to fda approved and covid-19 recommended drugs
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099028/
https://www.ncbi.nlm.nih.gov/pubmed/37362786
http://dx.doi.org/10.1007/s11696-023-02804-5
work_keys_str_mv AT chandragirish fluorineasmallmagicbulletatominthedrugdevelopmentperspectivetofdaapprovedandcovid19recommendeddrugs
AT singhdurgvijay fluorineasmallmagicbulletatominthedrugdevelopmentperspectivetofdaapprovedandcovid19recommendeddrugs
AT mahatogopalkumar fluorineasmallmagicbulletatominthedrugdevelopmentperspectivetofdaapprovedandcovid19recommendeddrugs
AT patelsamridhi fluorineasmallmagicbulletatominthedrugdevelopmentperspectivetofdaapprovedandcovid19recommendeddrugs